Chlorine in PDB 5vcv: Crystal Structure of Human MYT1 Kinase Domain in Complex with Dasatinib

Enzymatic activity of Crystal Structure of Human MYT1 Kinase Domain in Complex with Dasatinib

All present enzymatic activity of Crystal Structure of Human MYT1 Kinase Domain in Complex with Dasatinib:
2.7.11.1;

Protein crystallography data

The structure of Crystal Structure of Human MYT1 Kinase Domain in Complex with Dasatinib, PDB code: 5vcv was solved by J.-Y.Zhu, M.P.Martin, E.Schonbrunn, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 19.56 / 1.92
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 56.130, 68.630, 75.440, 90.00, 90.00, 90.00
R / Rfree (%) 15.6 / 19.7

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Crystal Structure of Human MYT1 Kinase Domain in Complex with Dasatinib (pdb code 5vcv). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total 3 binding sites of Chlorine where determined in the Crystal Structure of Human MYT1 Kinase Domain in Complex with Dasatinib, PDB code: 5vcv:
Jump to Chlorine binding site number: 1; 2; 3;

Chlorine binding site 1 out of 3 in 5vcv

Go back to Chlorine Binding Sites List in 5vcv
Chlorine binding site 1 out of 3 in the Crystal Structure of Human MYT1 Kinase Domain in Complex with Dasatinib


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Crystal Structure of Human MYT1 Kinase Domain in Complex with Dasatinib within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl401

b:19.2
occ:1.00
H A:ASP150 2.6 21.9 1.0
H A:LYS149 2.6 25.1 1.0
HA3 A:GLY147 2.7 24.3 1.0
HB3 A:LYS149 3.0 30.0 1.0
N A:LYS149 3.3 20.9 1.0
CA A:GLY147 3.3 20.3 1.0
C A:GLY147 3.4 19.4 1.0
HD2 A:PRO148 3.4 25.7 1.0
N A:ASP150 3.4 18.2 1.0
N A:PRO148 3.6 20.0 1.0
HB2 A:ASP150 3.7 22.5 1.0
CB A:LYS149 3.7 25.0 1.0
HB2 A:LYS149 3.8 30.0 1.0
O A:GLY147 3.8 18.4 1.0
CA A:LYS149 3.9 18.9 1.0
N A:GLY147 3.9 21.1 1.0
CD A:PRO148 3.9 21.4 1.0
HB3 A:ASP150 4.0 22.5 1.0
H A:GLY147 4.1 25.3 1.0
C A:LYS149 4.1 17.9 1.0
HA2 A:GLY147 4.2 24.3 1.0
CB A:ASP150 4.2 18.7 1.0
C A:PRO148 4.3 22.8 1.0
HD3 A:PRO148 4.4 25.7 1.0
CA A:ASP150 4.4 17.1 1.0
CA A:PRO148 4.5 19.4 1.0
C A:ARG146 4.5 20.3 1.0
O A:ARG146 4.7 21.5 1.0
HB2 A:ARG146 4.8 30.2 1.0
O A:HOH509 4.8 27.7 1.0
HA A:LYS149 4.8 22.7 1.0
HA A:ASP150 4.9 20.5 1.0
H A:ARG151 4.9 20.7 1.0

Chlorine binding site 2 out of 3 in 5vcv

Go back to Chlorine Binding Sites List in 5vcv
Chlorine binding site 2 out of 3 in the Crystal Structure of Human MYT1 Kinase Domain in Complex with Dasatinib


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 2 of Crystal Structure of Human MYT1 Kinase Domain in Complex with Dasatinib within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl402

b:23.7
occ:1.00
HD2 A:PHE106 2.8 22.3 1.0
OH A:TYR184 2.9 17.5 1.0
HH21 A:ARG140 2.9 34.0 1.0
OG A:SER104 2.9 15.6 1.0
HB3 A:PHE106 3.0 16.9 1.0
HG A:SER104 3.1 18.7 1.0
HE2 A:TYR184 3.2 18.6 1.0
HG3 A:GLN107 3.3 32.6 1.0
HD2 A:ARG140 3.3 26.1 1.0
HH A:TYR184 3.4 20.9 1.0
HB3 A:SER104 3.6 19.5 1.0
NH2 A:ARG140 3.6 28.4 1.0
CD2 A:PHE106 3.7 18.6 1.0
HD3 A:ARG140 3.7 26.1 1.0
CB A:SER104 3.7 16.3 1.0
CZ A:TYR184 3.8 17.0 1.0
CE2 A:TYR184 3.9 15.5 1.0
HB2 A:SER104 3.9 19.5 1.0
CB A:PHE106 3.9 14.0 1.0
HH22 A:ARG140 3.9 34.0 1.0
CD A:ARG140 4.0 21.8 1.0
H A:GLN107 4.1 18.8 1.0
CG A:GLN107 4.2 27.2 1.0
HB2 A:PHE106 4.3 16.9 1.0
CG A:PHE106 4.3 13.9 1.0
HG2 A:GLN107 4.4 32.6 1.0
O A:HOH560 4.5 26.7 1.0
OE1 A:GLN107 4.6 23.1 1.0
CZ A:ARG140 4.6 32.6 1.0
N A:GLN107 4.7 15.6 1.0
HE2 A:PHE106 4.7 22.4 1.0
CE2 A:PHE106 4.7 18.6 1.0
H A:PHE106 4.7 20.7 1.0
CD A:GLN107 4.7 27.6 1.0
NE A:ARG140 4.8 24.2 1.0
O A:HOH563 4.8 13.1 1.0
HG3 A:ARG140 4.8 21.3 1.0
HH11 A:ARG112 4.9 69.6 1.0

Chlorine binding site 3 out of 3 in 5vcv

Go back to Chlorine Binding Sites List in 5vcv
Chlorine binding site 3 out of 3 in the Crystal Structure of Human MYT1 Kinase Domain in Complex with Dasatinib


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 3 of Crystal Structure of Human MYT1 Kinase Domain in Complex with Dasatinib within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl404

b:16.8
occ:1.00
CL A:1N1404 0.0 16.8 1.0
C5 A:1N1404 1.7 14.1 1.0
H A:ASP251 2.6 15.1 1.0
C6 A:1N1404 2.7 13.1 1.0
C4 A:1N1404 2.7 12.1 1.0
H6 A:1N1404 2.8 15.8 1.0
N2 A:1N1404 3.0 11.3 1.0
HA3 A:GLY250 3.0 14.5 1.0
HG21 A:VAL171 3.2 16.1 1.0
HG13 A:VAL171 3.3 19.1 1.0
C3 A:1N1404 3.4 12.0 1.0
HN2 A:1N1404 3.4 13.6 1.0
HE1 A:PHE240 3.4 15.4 1.0
N A:ASP251 3.4 12.6 1.0
O A:1N1404 3.5 11.6 1.0
HG12 A:VAL171 3.6 19.1 1.0
OD1 A:ASP251 3.6 32.9 1.0
HB A:VAL171 3.6 13.5 1.0
CG1 A:VAL171 3.8 15.9 1.0
CE1 A:PHE240 3.8 12.8 1.0
CA A:GLY250 3.8 12.1 1.0
O A:HOH516 3.9 29.4 1.0
HG21 A:THR187 3.9 12.9 1.0
HA2 A:GLY250 3.9 14.5 1.0
CG2 A:VAL171 4.0 13.4 1.0
C7 A:1N1404 4.0 12.2 1.0
CB A:VAL171 4.0 11.3 1.0
C9 A:1N1404 4.0 10.6 1.0
C A:GLY250 4.1 13.7 1.0
HA A:ASP251 4.1 15.3 1.0
HE1 A:HIS161 4.2 21.3 1.0
CZ A:PHE240 4.3 13.4 1.0
HZ A:PHE240 4.3 16.0 1.0
C2 A:1N1404 4.3 12.7 1.0
CA A:ASP251 4.4 12.7 1.0
CD1 A:PHE240 4.4 12.9 1.0
HG23 A:VAL171 4.5 16.1 1.0
HD1 A:PHE240 4.5 15.5 1.0
C8 A:1N1404 4.5 10.9 1.0
CG A:ASP251 4.6 76.2 1.0
HG22 A:VAL171 4.6 16.1 1.0
HG11 A:VAL171 4.7 19.1 1.0
H1 A:1N1404 4.7 15.5 1.0
H7 A:1N1404 4.8 14.6 1.0
CG2 A:THR187 4.9 10.8 1.0
C1 A:1N1404 4.9 12.9 1.0
CB A:ASP251 5.0 12.9 1.0

Reference:

J.Y.Zhu, R.A.Cuellar, N.Berndt, H.E.Lee, S.H.Olesen, M.P.Martin, J.T.Jensen, G.I.Georg, E.Schonbrunn. Structural Basis of Wee Kinases Functionality and Inactivation By Diverse Small Molecule Inhibitors. J. Med. Chem. V. 60 7863 2017.
ISSN: ISSN 1520-4804
PubMed: 28792760
DOI: 10.1021/ACS.JMEDCHEM.7B00996
Page generated: Sat Dec 12 12:33:55 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy